FMP
Enter
Data
Fundamental StatementsForm 13FInsider & Congressional TradingAnalyst Estimates & Price TargetHistorical Market DataReal-Time WebSocketESG DataForex Market DataETF & Mutual FundCommodity Market DataIndex Market DataAdvanced Market MetricsEconomics DataSearch & DirectoryCrypto DataEarnings Call TranscriptsMarket CalendarCompany Profile
API Tools
Extras
Genprex, Inc.
GNPX
NASDAQ
Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes. Its lead product candidate is REQORSA (GPX-001) to treat non-small cell lung cancer and small cell lung cancer. The company is also developing GPX-002, a preclinical stage gene therapy for diabetes. Genprex, Inc. was incorporated in 2009 and is headquartered in Austin, Texas.
0.285 USD
-0.0016 (-0.561%)
